BioRestorative Therapies, Inc. Common Stock (NV)
$2.69
Market Cap
$3.72M
Shares Outstanding
1.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 22, 1997
Round Lot
100
Locale
US
Day Open
$2.71
Day High
$2.79
Day Low
$2.67
Volume
17.6K
VWAP
$2.74
Prev Close
$2.65
Transactions
--
Acc. Volume
--
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) closed the 2026-09-18 session at $2.69, up 1.32% versus the previous close (+0.04). The stock opened at $2.71 and traded between $2.67 and $2.79 during that session. Session trading volume was 18K shares. The volume-weighted average price (VWAP) is $2.74.
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
BioRestorative Therapies, Inc. Common Stock (NV) has a market capitalization of $3.7 million. The company operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry classification. BRTX is listed on the XNAS exchange. The company employs approximately 14 people. BioRestorative Therapies, Inc. Common Stock (NV) is headquartered in MELVILLE, NY. The recorded listing date is 1997-12-22.
On this page you can find market BRTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector.